Shares of Edwards Lifesciences Corp jumped 13 percent on Monday after a U.S. court temporarily halted sales of competitor Medtronic Inc's heart valve implant that uses a less-invasive procedure to spare patients from open-heart surgery. The ruling, by a U.S. District Court in Delaware on Friday, came after earlier court decisions that found Medtronic's CoreValve infringed on Edwards' Sapien transcatheter valve product. The court agreed to postpone implementation of the ruling for seven days to allow Medtronic to appeal. Medtronic on Monday said it filed a motion in appeals court seeking an emergency stay of the preliminary injunction. via Health News Headlines - Yahoo News Read More Here..
No comments:
Post a Comment